12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Company News  |  Deals

Marshall Edwards, Novogen deal

Marshall Edwards Inc. (NASDAQ:MSHL), San Diego, Calif.
Novogen Ltd. (ASX:NRT; NASDAQ:NVGN), North Ryde, Australia
Business: Cancer
Marshall Edwards agreed in principle to acquire all IP related to Novogen's isoflavone-related platform in a...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >